Brazil's pharma market has potential for 10% annual growth
Brazil’s pharma market has the potential to grow by more than 10% per year, according to the head of the department of chemical and pharmaceutical intermediaries from the Brazilian Development Bank, reported by Brazil Pharma News.
The Brazilian pharmaceutical market has boomed over the past decade, and found new challenges in the form of changing dynamics of the global pharma market and need for the production of high-tech biological drugs.
Peter Palmeira, of the Brazilian Development Bank, said: "The next few years will be decisive for the consolidation of the strategy designed in recent years, with the development and registration of products and the beginning of industrial activities. Our portfolio of contracted projects reflects this challenge well. Over the past two years, the Brazilian Development Bank contracted 11 projects related to biotechnology, totaling 1.3 billion real [$569 million], compared to 150 million real in the last decade."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze